Literature DB >> 27999942

The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study.

Yan Liang1, Rui-Xue Leng1, Hai-Feng Pan1, Dong-Qing Ye2.   

Abstract

This study aims to estimate the prevalence of serositis and identify risk factors for serositis in a large cohort of systemic lupus erythematosus (SLE) patients. A cross-sectional study was conducted based on the medical records of patients hospitalized with SLE at the First Affiliated Hospital of Anhui Medical University and Anhui Provincial Hospital. Patients were diagnosed with serositis when they presented with symptoms and signs of pleuritis or/and pericarditis. We explored factors associated with the generation and quantity of serositis by using binary and ordinal logistic regression analysis. Among the 1668 lupus patients, 298 have serositis. Active lupus disease, fever (≥38 °C) and high D-dimer were all significantly associated with the generation and quantity of serositis. Male gender was independent significant risk factor for pleuritis but not for pericarditis, while low complement C4 and high erythrocyte sedimentation rate (ESR) were risk factors for pericarditis rather than for pleuritis. The possible prevalence of serositis in patients with SLE was 17.9%. The significant associations of active lupus disease, fever (≥38 °C) and high D-dimer with serositis suggest that higher disease activity and hypercoagulability may both contribute to the generation and development of serositis in SLE. The risk factors for pleuritis and pericarditis in SLE are similar but not identical.

Entities:  

Keywords:  Pericarditis; Pleuritis; Risk factor; Serositis; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2016        PMID: 27999942     DOI: 10.1007/s00296-016-3630-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  17 in total

1.  The use of streptokinase-streptodornase in the treatment of postneumonic empyema.

Authors:  W S TILLETT; S SHERRY; C T READ
Journal:  J Thorac Surg       Date:  1951-03

2.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Coagulation factors and fibrinogen in pleural effusions.

Authors:  F L Glauser; P T Otis; R I Levine; W R Smith
Journal:  Respiration       Date:  1976       Impact factor: 3.580

5.  Abnormalities of pathways of fibrin turnover in the human pleural space.

Authors:  S Idell; W Girard; K B Koenig; J McLarty; D S Fair
Journal:  Am Rev Respir Dis       Date:  1991-07

6.  Large pericardial effusions due to systemic lupus erythematosus: a report of eight cases.

Authors:  H S v H Weich; L J Burgess; H Reuter; E A Brice; A F Doubell
Journal:  Lupus       Date:  2005       Impact factor: 2.911

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Cardiac involvement in systemic lupus erythematosus detected by echocardiography.

Authors:  I G Crozier; E Li; M J Milne; M G Nicholls
Journal:  Am J Cardiol       Date:  1990-05-01       Impact factor: 2.778

9.  Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease.

Authors:  C Strange; M H Baumann; S A Sahn; S Idell
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

Review 10.  SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.

Authors:  Yan Liang; Wang-Dong Xu; Hui Peng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Eur J Immunol       Date:  2014-03-27       Impact factor: 5.532

View more
  9 in total

Review 1.  Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab.

Authors:  Irene Carrión-Barberà; Tarek Carlos Salman-Monte; Sonia Castell; Francisco Castro-Domínguez; Fabiola Ojeda; Jordi Monfort
Journal:  Eur J Rheumatol       Date:  2019-05-20

Review 2.  Sex Differences in Pediatric Rheumatology.

Authors:  Marco Cattalini; Martina Soliani; Maria Costanza Caparello; Rolando Cimaz
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

3.  Relationship between hyperuricemia and serositis in patients with lupus nephritis.

Authors:  Ping Nie; Liangqian Hu; Bing Li; Yan Lou; Manyu Luo; Yali Wang; Xuehong Lu; Ping Luo
Journal:  Int Urol Nephrol       Date:  2021-05-10       Impact factor: 2.370

4.  Coagulation cascade and complement system in systemic lupus erythematosus.

Authors:  Yan Liang; Shang-Bo Xie; Chang-Hao Wu; Yuan Hu; Qin Zhang; Si Li; Yin-Guang Fan; Rui-Xue Leng; Hai-Feng Pan; Hua-Bao Xiong; Dong-Qing Ye
Journal:  Oncotarget       Date:  2017-12-11

5.  Associated clinical factors for serious infections in patients with systemic lupus erythematosus.

Authors:  Ju-Yang Jung; Dukyong Yoon; Young Choi; Hyoun-Ah Kim; Chang-Hee Suh
Journal:  Sci Rep       Date:  2019-07-04       Impact factor: 4.379

6.  Sex differences in clinical presentation of systemic lupus erythematosus.

Authors:  Jorge I Ramírez Sepúlveda; Karin Bolin; Johannes Mofors; Dag Leonard; Elisabet Svenungsson; Andreas Jönsen; Christine Bengtsson; Gunnel Nordmark; Solbritt Rantapää Dahlqvist; Anders A Bengtsson; Lars Rönnblom; Christopher Sjöwall; Iva Gunnarsson; Marie Wahren-Herlenius
Journal:  Biol Sex Differ       Date:  2019-12-16       Impact factor: 5.027

7.  Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.

Authors:  Nellie Bourse Chalvon; Pauline Orquevaux; Delphine Giusti; Gregory Gatouillat; Thierry Tabary; Marcelle Tonye Libyh; Jan Chrusciel; Moustapha Drame; Grace Stockton-Bliard; Zahir Amoura; Laurent Arnaud; Hanns-Martin Lorenz; Gilles Blaison; Bernard Bonnotte; Nadine Magy-Bertrand; Sabine Revuz; Reinhard Edmund Voll; Oliver Hinschberger; Andreas Schwarting; Bach Nga Pham; Thierry Martin; Jean-Loup Pennaforte; Amelie Servettaz
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

8.  Clinical characteristics of systemic lupus erythematosus with chylothorax and/or chylous ascites: An analysis of 15 cases in China.

Authors:  Guo-Hua Zhang; Ling-Ling Zhang; Yu-Hua Wang; Wen-Bin Shen
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

9.  Sjögren's syndrome.

Authors:  Fiona André; Barbara C Böckle
Journal:  J Dtsch Dermatol Ges       Date:  2022-07-01       Impact factor: 5.231

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.